Yellow pigment in eye may aid vision through haze, suggests Optometry and Vision Science

(Press-News.org) August 25, 2014 – Individuals with greater amounts of yellow pigment in the eye may be better able to see distant objects in hazy conditions, suggests a study in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Increased macular pigment (MP) may help in filtering out "blue haze," thus making distant objects more visible, according to the experimental study by Laura M. Fletcher, MS, and colleagues of University of Georgia, Athens. "The results suggest that people with high levels of yellow macular pigment may have some slight advantage in hazy and glare conditions," comments Anthony Adams, OD, PhD, Editor-in-Chief of Optometry and Vision Science.

Macular Pigment Affects Vision through 'Blue Haze' The researchers tested the effects of MP on the ability to see distant objects through "atmospheric scattering," or haze. "All human eyes, and many animal eyes, contain an inert yellow pigment that is reported to be both protective and also slightly enhance vision, particularly in short wavelength (blue light) settings," Dr Adams explains. Some people have more MP than others.

The researchers designed an experiment to simulate hazy conditions to see if individuals with higher levels of MP can better see distant targets. Laboratory studies were performed using xenon light, paired with a specialized glass filter, to closely approximate the effects of atmospheric haze. The subjects varied widely in the density of MP present in the eye.

At increasing levels of simulated blue haze background, the visibility of distant objects decreased significantly. However, individuals with higher levels of MP required more stimulated haze before they could no longer see the distant target.

For subjects with the highest versus lowest levels of MP, there was about a twofold difference in the amount of haze required to lose sight of the distant object. The researchers write, "An individual with high MP optical density would be able to detect a target at a much greater distance (ie, more atmospheric haze between them and the target) than an individual with lower MP optical density."

Can Increased Macular Pigment Improve Outdoor Vision? The presence of yellow pigment in the macula represents accumulations of the nutrients lutein and zeaxanthin. By filtering out short-wave light, MP may protect long-term damage to the eye.

But from an evolutionary standpoint, it's much more likely that accumulations of MP could develop as a result of favorable effects on vision. The new findings support the "visibility hypothesis" of MP accumulation: by absorbing atmospheric haze, which is predominantly short-wavelength light, the presence of MP may extend visual range outdoors.

In this experiment, the effect seems large enough to provide a visual advantage of higher levels of MP for people who rely heavily on outdoor vision—for example, pilots. According to Fletcher and coauthors, the next "obvious step" in research would be to test the effects of different levels of MP on visibility in outdoor settings.

Click here to read "Visibility through Atmospheric Haze and Its Relation to Macular Pigment."

INFORMATION: About Optometry and Vision Science Optometry and Vision Science, official journal of the American Academy of Optometry, is the most authoritative source for current developments in optometry, physiological optics, and vision science. This frequently cited monthly scientific journal has served primary eye care practitioners for more than 75 years, promoting vital interdisciplinary exchange among optometrists and vision scientists worldwide.

About the American Academy of Optometry Founded in 1922, the American Academy of Optometry is committed to promoting the art and science of vision care through lifelong learning. All members of the Academy are dedicated to the highest standards of optometric practice through clinical care, education or research.

About Wolters Kluwer Health Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle: @WKHealth.